advanced research tirzepatide vs Retatrutide: GLP-1 Comparison TIRZEPATIDE – Research Peptide |

Updated July 2026 The Ozempic and GLP-1 lawsuits involve claims that manufacturers of medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Zepbound, and Saxenda failed to adequately warn patients and doctors about potential risks of developing gastroparesis (stomach paralysis), ileus (bowel obstruction), deep vein thrombosis (DVT), intraoperative pulmonary aspiration and NAION eye injury (sudden vision loss)

Its triple-agonist design targeting GLP-1, GIP, and glucagon receptors produced up to 24% body weight loss in research settings

Wish Id started sooner! Simple process from beginning to end

Improvements are usually noticeable within 24 months , but achieving full results often requires 6 months or more

Under close medical supervision, well regularly assess your weight loss, crucial signs, and any potential side effects to safeguard optimal results with this compound medication

Theyre seeing a GI doctor for a colonoscopy